This FAQ summarizes a Special Report discussion on testosterone pellet therapy in women and advice for hesitant prescribers.
|Articles|November 30, 2018
Video: Laparoscopic excision of multifocal bowel endometriosis
Nisse V. Clark, MD, Renita Kim, MD, MPH, and Jon Einarsson, MD, PhD, MPH show how they treat multifocal bowel endometriosis in a 25-year-old G0 with dysmenorrhea, dyschezia, and cyclic rectal bleeding.
Advertisement
Nisse V. Clark, MD, Renita Kim, MD, MPH, and Jon Einarsson, MD, PhD, MPH show how they treat multifocal bowel endometriosis in a 25-year-old G0 with dysmenorrhea, dyschezia, and cyclic rectal bleeding.
Advertisement
Related to this article
This FAQ summarizes a Special Report discussion on off-label testosterone dosing, application, cost, and lab monitoring in women.
This FAQ summarizes a Special Report discussion on how two experts decide who is a candidate for testosterone therapy in women, from symptoms and context to hormone state vs age.
This FAQ summarizes a Special Report discussion of what the evidence does and does not establish about testosterone therapy in women.
A recap of the top women's health headlines from October 2026, including FDA approval of pritelivir for refractory HSV, ACOG's new menopause guideline, and more.
Risa Kagan, MD, on bone health prevention in primary care and why baseline bone density testing should come before age 65.
Patients with 3 or more adverse pregnancy outcomes had lower odds of postpartum contraceptive use in a PRAMS analysis of 222,412 individuals.
Risk factors cast a wide net in preeclampsia prediction, but biomarkers could add precision, according to Dallas Reed, MD.
Advertisement
Advertisement